High-Response Rates from both Selinexor and Velcade The combination of the two show synergy against Myeloma - 101931

Spotlight
Video

High-Response Rates from both Selinexor and Velcade The combination of the two show synergy against Myeloma

ASHReport has 256 videos Subscribe Here

Loading........
Description: Michael Kauffman, MD and CEO from Karyopharm Therapeutics Inc discusses high-response rates from both Selinexor and velcade and the combination of the two show synergy against myeloma at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/22/18
Added : 3 months ago
Category : Multiple Myeloma